Loading clinical trials...
Loading clinical trials...
RATIONALE: Estrogen can stimulate the growth of endometrial cancer cells. Hormone therapy using raloxifene may fight endometrial cancer by reducing the production of estrogen. PURPOSE: Phase II trial...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Northwestern University
Collaborators
NCT06840886 · Advanced Solid Tumors, Ovarian Cancer, and more
NCT06989112 · Endometrial Cancer
NCT07044336 · Endometrial Cancer, Malignant Solid Tumour
NCT07041606 · Endometrial Cancer
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions